14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Volatile ride for Zomedica Pharmaceuticals Corp stock price on Tuesday moving between $0.37 and $0.41

StockInvest.us, 2 months ago


The Zomedica Pharmaceuticals Corp stock price gained 11.00% on the last trading day (Tuesday, 1st Mar 2022), rising from $0.36 to $0.40. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 10.63% from a day low at $0.37 to a day high of $0.41. The price has risen in 7 of the last 10 days and is up by 37.35% over the past 2 weeks. Volume fell on the last day by -23 million shares and in total, 25 million shares were bought and sold for approximately $9.82 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

HC Wainwright is very positive about ZOM and gave it a "Buy" rating on Nov 16, 2020. The price target was changed from $0.50 to $0.30.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.40, a level that may pose a second chance to hit a runner. According to fan-theory $0.52 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Zomedica Pharmaceuticals Corp

The Zomedica Pharmaceuticals Corp stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.36 and $0.32. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, February 17, 2022, and so far it has fallen -0.1000%. Further fall is indicated until a new bottom pivot has been found.

On the downside, the stock finds support just below today's level from accumulated volume at $0.36 and $0.36.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zomedica Pharmaceuticals Corp finds support just below today's level at $0.36. If this is broken, then the next support from accumulated volume will be at $0.36 and $0.35.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0390 between high and low, or 10.63%. For the last week, the stock has had a daily average volatility of 17.58%.

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Check full Zomedica Pharmaceuticals Corp forecast and analysis here.